ДЕЦИСАН

Product Overview

About ДЕЦИСАН

ДЕЦИСАН is a medication that contains the active ingredient Decitabine, which is used in the treatment of certain types of cancer. Decitabine belongs to a class of medications known as hypomethylating agents, which work by helping to restore normal functioning of the genes in cancer cells. ДЕЦИСАН is specifically designed to target and treat myelodysplastic syndromes, a group of disorders caused by poorly formed or dysfunctional blood cells.

Key Benefits & Uses

• Treatment of myelodysplastic syndromes, including refractory anemia, refractory anemia with ringed sideroblasts, and chronic myelomonocytic leukemia
• Improvement of blood cell counts, reducing the need for blood transfusions
• Potential to delay the progression of myelodysplastic syndromes to acute myeloid leukemia

Active Ingredient & Action

Decitabine, the active ingredient in ДЕЦИСАН, works by inhibiting DNA methyltransferase, an enzyme responsible for the methylation of DNA. This leads to a decrease in DNA methylation, which can help to reactivate genes that have been silenced by methylation, thereby promoting normal cell function and differentiation.

Important Notes

ДЕЦИСАН should only be used under the supervision of a qualified healthcare professional. Patients should be closely monitored for potential side effects, including myelosuppression, infection, and gastrointestinal toxicity. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse effects.